PAK1 was previously reported to regulate cancer cell metabolism and proliferation [29, 30] and BCAT1 is implicated in cancer metabolic reprogramming, tumour metastasis and drug resistance [31, 32, 33]. This evidence concerns the gene BCAT1 and neoplasm.